Getting your player ready...
The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency’s sternest warning because of its bleeding risks.
The approval makes Lilly’s Effient the first real competition to the blood thinner Plavix, the world’s second-best- selling medication, made by Sanofi-Aventis and Bristol- Myers Squibb.
